Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.22 -0.18 (7.5%)
Previous Close $2.40    52 Week High $3.64 
Open $2.37    52 Week Low $0.14 
Day High $2.38    P/E N/A 
Day Low $2.22    EPS $0.00 
Volume 39,756